Orthofix International reported $-2.19M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Dexcom USD 269.5M 71.2M Mar/2026
EDAP TMS EUR -8.94M 4.03M Mar/2026
Globus Medical USD 157.07M 12.16M Mar/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 118.7M 5.7M Jun/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
J&J USD 8.66B 839M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -2.19M 20.07M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Smith & Nephew USD 469M 70M Dec/2025
STAAR Surgical USD 8.22M 28.87M Mar/2026
Stryker USD 850M 855M Mar/2026
Tandem Diabetes Care USD -19.88M 24.56M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
Veracyte USD 26.52M 3.45M Jun/2026
Zimmer Biomet Holdings USD 487.5M 186.2M Jun/2026